Literature DB >> 32163103

An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor.

Ryan S Kim1, Antonio Yaghy1, Lindsay R Wilde2, Carol L Shields1.   

Abstract

Entities:  

Year:  2020        PMID： 32163103     DOI： 10.1001/jamaophthalmol.2020.0110

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  3 in total

Review 1.  Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field.

Authors:  Andrea Duminuco; Cinzia Maugeri; Marina Parisi; Elisa Mauro; Paolo Fabio Fiumara; Valentina Randazzo; Domenico Salemi; Cecilia Agueli; Giuseppe Alberto Palumbo; Alessandra Santoro; Francesco Di Raimondo; Calogero Vetro
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

2.  Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma - A Case Report.

Authors:  Nancy Chen; Chia-Shuen Lin; Yung-Hsiang Hsu; Wei-Han Huang; Chin-Te Huang; Yuan-Chieh Lee
Journal:  Int Med Case Rep J       Date:  2021-06-30

3.  Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab.

Authors:  Margaret Wong; James H Frank; Carol L Shields
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.